3,750,000 Common Shares TEKMIRA PHARMACEUTICALS CORPORATION (incorporated under the Business Corporations Act (British Columbia)) UNDERWRITING AGREEMENTUnderwriting Agreement • October 17th, 2013 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Tekmira Pharmaceuticals Corporation, a company incorporated under the Business Corporations Act (British Columbia) (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom Stifel Nicolaus & Company, Incorporated is acting as representative (the “Representative”), an aggregate of 3,750,000 common shares (the “Firm Shares”) of the Company (the “Common Shares”). The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 562,500 additional Common Shares, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
